Discontinued Operations (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Jun. 30, 2012	Jun. 30, 2012
Discontinued Operations (Textual) [Abstract]
Total Consideration received from the Pharma Sale			$ 30,000,000
Loss on sale of discontinued operations, net of income taxes		(82,000)	(1,015,000)
Income tax benefit			1,000,000
Transaction costs			1,700,000
Asset impairment charges totaling	28,100,000
Impairment of long lived fixed assets disposed	23,300,000
Impairment of long lived intangible assets disposed	4,800,000
Restricted time period for competition			5 years
Deferred tax assets and retained liability		$ 1,700,000	$ 1,700,000